Your Global Leader in Stem Cell Market Research
BioInformant's coverage of stem cell news includes iPS cells, mesenchymal stem cells, hematopoietic stem cells, neural stem cells and more.
As the first and only market research firm to specialize in stem cell news, BioInformant research has been cited by the Wall Street Journal, Xconomy, AABB, and Vogue Magazine.
Serving Fortune 500 leaders that include GE Healthcare, Pfizer, and Goldman Sachs, BioInformant is your global leader in stem cell industry news.
MINNEAPOLIS, MN, USA, July 7, 2020– Luminary Therapeutics (Luminary Tx) and Case Western Reserve University have entered into a formal collaboration agreement that includes an option for Luminary to exclusively license a novel BAFF target for use in CAR-T (chimeric antigen receptor T cells) constructs. [Read more…]
Extracellular vesicles (EVs) are known for their role in facilitating wide range of intercellular communication such as regulation of the immune response and stem cells differentiation.
EVs are membrane-enclosed particles ranging in size from 30nm to 300nm and their characteristic depend on the cell type releasing them. Often they will carry cargo of active molecules like RNA, DNA, proteins, metabolites and lipids. Moreover, EVs can be found in most biological fluids with the ability to cross biological barriers, and in the case of pathological conditions, the composition of the cargo will be distinctive to the disease. Altogether, these features have led to intense research into the potential role of EVs for diagnostics, biomarkers and as vehicles for drug delivery. [Read more…]
On August 2-4, 2019, the American Academy of Stem Cell Physicians hosted a Scientific Congress at the Hyatt Regency in Miami, Florida. The highly anticipated event featured three days of educational and events with leading physicians and pioneers from across the fields of stem cell, live cell and regenerative medicine.
During this event, the AASCP Scientific Congress offered the first Board Certifications to eligible stem cell physicians. A challenging three-hour written examination for Board Certification was conducted, creating a pathway for Diplomat and Fellowship Certification in Regenerative Medicine (RM).
This year, the AASCP’s Congress will be delivered over August 1-2, 2020, and will include the first Virtual Board Certification for Stem Cell Physicians. [Read more…]
ORLANDO, Fla., July 6, 2020 – Aspire Health Science, LLC (the “Company” or “Aspire”), is an FDA registered cGMP manufacturing facility specializing in the research, development, and manufacturing of cell-based therapies. [Read more…]
